Cerba HealthCare, a France-based global player in medical diagnosis, has acquired Cirion Biopharma Research, a Canadian-controlled private CRO recognized for its integrated bioanalytical and global central laboratory services. Cirion has been operating global clinical trials over 30 years. Besides its bioanalytical capabilities in biosimilars/biologics development, it offers central lab full solutions with fast start-up capabilities…